Imagine it’s 2030, what do you expect your greatest health needs will be?
For 69% of consumers, the answer is joint and mobility health.
Yet, many existing joint health solutions fall short in addressing persistent discomfort, stiffness, and long-term flexibility. Now, a next-generation Boswellia extract, highly concentrated and water-dispersible, offers a smarter, more effective way to bridge these gaps.
Key Features & Benefits:
- Standardized to >40% Acetyl keto-β-Boswellic acid (AKBA) —13 times higher than standard Boswellia extracts
- 6% reduction in joint stiffness
- 7% reduction in joint pain
- 0% improvement in physical functioning
For formulators and brand owners, this signals a powerful opportunity to lead in the fast-growing mobility space with solutions that are both science-backed and consumer-trusted.
What are you waiting for? Partner with ITS Nutriscience to shape the next generation of joint health solutions.
